ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,021 | -13.0% | 3,120 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $74,724 | +126550.8% | 3,120 | 0.0% | 0.00% | – |
| Q1 2023 | $59 | +227.8% | 3,120 | +169.0% | 0.00% | – |
| Q4 2022 | $18 | -99.9% | 1,160 | +2.1% | 0.00% | – |
| Q3 2022 | $18,000 | -14.3% | 1,136 | -22.6% | 0.00% | – |
| Q2 2022 | $21,000 | -86.2% | 1,467 | -76.6% | 0.00% | -100.0% |
| Q1 2022 | $152,000 | -33.0% | 6,267 | -54.1% | 0.00% | 0.0% |
| Q3 2021 | $227,000 | -36.2% | 13,648 | -6.5% | 0.00% | -50.0% |
| Q2 2021 | $356,000 | +24.5% | 14,601 | +31.6% | 0.00% | 0.0% |
| Q1 2021 | $286,000 | -51.8% | 11,091 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $593,000 | +244.8% | 11,091 | +165.8% | 0.00% | +300.0% |
| Q3 2020 | $172,000 | -43.4% | 4,172 | -33.4% | 0.00% | -66.7% |
| Q2 2020 | $304,000 | +16.5% | 6,268 | +1.4% | 0.00% | 0.0% |
| Q1 2020 | $261,000 | +0.4% | 6,182 | +1.8% | 0.00% | +50.0% |
| Q4 2019 | $260,000 | +170.8% | 6,072 | +127.4% | 0.00% | +100.0% |
| Q3 2019 | $96,000 | +43.3% | 2,670 | +6.8% | 0.00% | 0.0% |
| Q2 2019 | $67,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $67,000 | +67.5% | 2,500 | 0.0% | 0.00% | – |
| Q4 2018 | $40,000 | -23.1% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $52,000 | -14.8% | 2,500 | -37.5% | 0.00% | -100.0% |
| Q2 2018 | $61,000 | +96.8% | 4,000 | +185.7% | 0.00% | – |
| Q1 2018 | $31,000 | -26.2% | 1,400 | 0.0% | 0.00% | – |
| Q4 2017 | $42,000 | -41.7% | 1,400 | -26.7% | 0.00% | -100.0% |
| Q3 2017 | $72,000 | +35.8% | 1,910 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $53,000 | -65.8% | 1,910 | -57.6% | 0.00% | -50.0% |
| Q1 2017 | $155,000 | +34.8% | 4,510 | +12.8% | 0.00% | +100.0% |
| Q4 2016 | $115,000 | +259.4% | 4,000 | +300.0% | 0.00% | – |
| Q3 2016 | $32,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $32,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $28,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |